It is found that hyperinsulinemia, proinsulin/insulin ratio and the number of apoptotic β-cells were all reduced, and the insulin resistance was improved following 21-days administration of DC260126 in db/db mice. The gene discussed is INS; the disease is hyperinsulinism.